24.02.2013 Views

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

protein (e.g. Smith et al, 1995; Fong et al, 1995; Shalaby<br />

et al, 1995).<br />

<strong>Gene</strong> transfer to the embryo has shown the importance<br />

of the promoter, large genomic regulatory regions, cellcell<br />

interactions and gene switch taking place during<br />

embryogenesis in maintaining transgene expression in<br />

different tissues; results obtained in embryos reflect the in<br />

vivo patterns of tissue-specific expression which could be<br />

useful to direct efforts in promoter choices for somatic<br />

gene transfer to the adult (as is the case for most gene<br />

<strong>therapy</strong> applications). Furthermore these studies provide<br />

the foundation of a new era where genetic manipulation of<br />

the embryo could permanently correct monogenic genetic<br />

disorders such as hemophilias, thalassemias and others.<br />

The promoter of the tie gene, which encodes a receptor<br />

tyrosine kinase that is expressed in the endothelium of<br />

blood vessels, was used to drive the expression of a<br />

luciferase reporter gene construct; in cultured cells the<br />

luciferase activity was not restricted to endothelial cells. In<br />

contrast, in transgenic mice expression of the reporter βgalactosidase<br />

was restricted to endothelial cells<br />

undergoing vasculogenesis and angiogenesis; in adult<br />

transgenic mice, tie promoter activity in lung and many<br />

vessels of the kidney was as high as in the vessels of the<br />

corresponding embryonic tissues, whereas in the heart,<br />

brain and liver, tie promoter activity was downregulated<br />

and restricted to coronaries, cusps, capillaries, and arteries<br />

(Korhonen et al, 1995).<br />

<strong>Gene</strong> Therapy and <strong>Molecular</strong> <strong>Biology</strong> Vol 1, page 85<br />

85<br />

A retroviral VEGF expression vector was used to<br />

infect quail ebryo and to increase the level of VEGF<br />

during critical periods of avian limb bud growth and<br />

morphogenesis. Overexpression of VEGF in the limb bud<br />

exclusively resulted in hypervascularization as reflected<br />

by an increase in vascular density from an augmentation<br />

of the VEGF signaling mechanism in a permissive<br />

environment; vascular permeability was also dramatically<br />

increased leading to local edema (Flamme et al, 1995).<br />

An avian leukosis virus (ALV)-based retroviral vector<br />

system was used for the efficient delivery of genes into<br />

preimplantation mouse embryos; a subset of the integrated<br />

proviruses expressed the delivered chloramphenicol<br />

acetyltransferase (CAT) reporter gene either from the<br />

constitutive viral promoter contained in the long terminal<br />

repeat or from the internal nonviral tissue-specific<br />

promoter in different sets of experiments. Thus, many of<br />

the sites that are accessible to viral DNA insertion in<br />

preimplantation embryos were thought to be incompatible<br />

with expression in older animals (Federspiel et al, 1996).<br />

Baldwin and coworkers (1997) have found that the<br />

expression of lacZ gene under control of CMV or RSV<br />

promoter transferred to early, postgastrulation mouse<br />

embryos gave tissue-specific patterns of expression which<br />

depended on the type of promoter used. Embryos were<br />

injected into the mesoderm of the neural fold (A in Figure<br />

30) and β-galactosidase activity was detected in the head

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!